Tabela 2. Routine semen assessment before and after antioxidative supplementation.
  All patients Normozoospermic patients Oligozoospermic patients Asthenozoospermic patients OAT patients
Before treat ment After anti-oxida tive intake p- value Before treat ment After anti-oxida tive intake p- value Before treat ment After anti-oxida tive intake p- value Before treat ment After anti-oxida tive intake p- value Before treat ment After anti-oxida tive intake p- value
MSOME criteria   Grade I 5.1 ± 5.4 6.6 ± 6.7 * 7.2 ± 6.1 8.3 ± 6.3 n.s. 3.4 ± 3.2 10.8 ± 7.5 * 5.1 ± 5.2 8.4 ± 7.0 * 2.6 ± 4.0 5.0 ± 7.2 n.s.
Grade II 39.7± 15.5 42.9 ± 14.6 n.s. 44.4± 13.0 47.1 ± 12.5 n.s. 47.1 ± 12.2 43.9 ± 9.0 n.s. 42.5± 11.7 41.8 ± 11.6 n.s. 26.9± 15.7 37.4 ± 15.8 **
Grade III 55.2± 18.1 50.5 ± 18.2 * 48.4 ± 15.6 44.6 ± 14.5 n.s. 49.5.0 ± 14.4 45.3 ± 10.2 * 52.4 ± 13.1 49.8 ± 14.8 * 70.5± 17.7 57.6 ± 20.1 **
Oligoasthenoteratozoospermia was defined according to WHO criteria. OAT= oligoasthenoteratozoospermia; n.s. = not significant; * = p< 0.05; **= p< 0.01; *** = p< 0.001